Cystathionine as a marker for 1p/19q codeleted gliomas by in vivo magnetic resonance spectroscopy
出版年份 2019 全文链接
标题
Cystathionine as a marker for 1p/19q codeleted gliomas by in vivo magnetic resonance spectroscopy
作者
关键词
-
出版物
NEURO-ONCOLOGY
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2019-01-31
DOI
10.1093/neuonc/noz031
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate
- (2018) Ovidiu C. Andronesi et al. Nature Communications
- Current therapeutic approaches to diffuse grade II and III gliomas
- (2018) Alberto Picca et al. Therapeutic Advances in Neurological Disorders
- Modulating the therapeutic response of tumours to dietary serine and glycine starvation
- (2017) Oliver D. K. Maddocks et al. NATURE
- Highly specific determination of IDH status using edited in vivo magnetic resonance spectroscopy
- (2017) Francesca Branzoli et al. NEURO-ONCOLOGY
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Cystathionine: A novel oncometabolite in human breast cancer
- (2016) Suvajit Sen et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma
- (2016) Changho Choi et al. JOURNAL OF CLINICAL ONCOLOGY
- Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth
- (2016) Shira L Cramer et al. NATURE MEDICINE
- Integrated multi-omics analysis of oligodendroglial tumours identifies three subgroups of 1p/19q co-deleted gliomas
- (2016) Aurélie Kamoun et al. Nature Communications
- Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression
- (2015) Isaac S. Harris et al. CANCER CELL
- Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion
- (2015) Kensuke Tateishi et al. CANCER CELL
- Radioprotection of IDH1-Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198
- (2015) R. J. Molenaar et al. CANCER RESEARCH
- Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- IDH1 Mutations Alter Citric Acid Cycle Metabolism and Increase Dependence on Oxidative Mitochondrial Metabolism
- (2014) A. R. Grassian et al. CANCER RESEARCH
- Decreased Expression of Cystathionine β-Synthase Promotes Glioma Tumorigenesis
- (2014) Naoharu Takano et al. MOLECULAR CANCER RESEARCH
- The epidemiology of glioma in adults: a "state of the science" review
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- 3D GABA imaging with real-time motion correction, shim update and reacquisition of adiabatic spiral MRSI
- (2014) Wolfgang Bogner et al. NEUROIMAGE
- An ANOCEF Genomic and Transcriptomic Microarray Study of the Response to Irinotecan and Bevacizumab in Recurrent Glioblastomas
- (2014) Julien Laffaire et al. Biomed Research International
- Brain dynamic neurochemical changes in dystonic patients: A magnetic resonance spectroscopy study
- (2012) Malgorzata Marjańska et al. MOVEMENT DISORDERS
- 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas
- (2012) Changho Choi et al. NATURE MEDICINE
- Detection of 2-Hydroxyglutarate in IDH-Mutated Glioma Patients by In Vivo Spectral-Editing and 2D Correlation Magnetic Resonance Spectroscopy
- (2012) O. C. Andronesi et al. Science Translational Medicine
- The transsulfuration pathway: a source of cysteine for glutathione in astrocytes
- (2011) Gethin J. McBean AMINO ACIDS
- Isocitrate dehydrogenase mutations in gliomas
- (2011) Changcun Guo et al. CURRENT OPINION IN NEUROLOGY
- Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
- (2011) Christian M. Metallo et al. NATURE
- Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome
- (2011) Z. J. Reitman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The prognostic IDH1 R132 mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma
- (2010) Fonnet E. Bleeker et al. ACTA NEUROPATHOLOGICA
- Inhibition of Glutaminase Preferentially Slows Growth of Glioma Cells with Mutant IDH1
- (2010) M. J. Seltzer et al. CANCER RESEARCH
- Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
- (2009) Marc Sanson et al. JOURNAL OF CLINICAL ONCOLOGY
- Cystathionine γ-lyase: Clinical, metabolic, genetic, and structural studies
- (2009) Jan P. Kraus et al. MOLECULAR GENETICS AND METABOLISM
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2009) Lenny Dang et al. NATURE
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
- Somatic Pairing of Chromosome 19 in Renal Oncocytoma Is Associated with Deregulated ELGN2-Mediated Oxygen-Sensing Response
- (2008) Julie M. Koeman et al. PLoS Genetics
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started